Skip to content

Eccentric Exercise in Epicondylitis

Eccentric Exercise in Epicondylitis: Direct Application By Physical Therapist Vs Self-Application By Patient

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03996928
Enrollment
20
Registered
2019-06-25
Start date
2017-01-01
Completion date
2019-12-01
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy

Keywords

Epicondylitis, Tennis elbow, Eccentric exercise

Brief summary

There is more and more evidence of the importance of the role of kinesitherapy in the management of epicondylitis, specifically (but not exclusively) of eccentric exercise. Since eccentric kinesitherapy, when applied in a systematic way by a physiotherapist, consumes time and human resources in a significant way, and in the case of such a prevalent pathology, it is frequent that strategies of training the patient are addressed so that this is who perform the exercises after learning them. However, it is not proven that the efficacy and safety of this approach is equivalent to treatment applied by a physiotherapist. A randomized single-blind controlled trial is conducted that compares both treatment approaches for epicondylitis (eccentric exercises applied directly by a physiotherapist for 10 sessions, and eccentric exercises applied by the patient during the same time) in terms of efficacy against pain, functionality and patient satisfaction, all this within the framework of the public health system.

Detailed description

The main objective of this study is: To compare the efficacy of an eccentric exercise program applied to patients with epicondylosis by a structured manual program in ten sessions and by an illustrated booklet. The specific objectives of this study are: Compare the effectiveness of the above-cited approaches in terms of pain Compare the effectiveness of the above-cited approaches in terms of function Compare the effectiveness of the above-cited approaches in terms of satisfaction

Interventions

OTHERExercise

Sponsors

Andaluz Health Service
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Single blind randomized controlled trial INDEPENDENT VARIABLES Age, Sex, Work activity (referred to a superior member): intense -including, among other kind of activities, keyboards users and housewives-light. Basal pain according to visual analogue scale (VAS) of 100 mm. Baseline disability according to the DASH questionnaire (Disabilities of the Arm, Shoulder and Hand), which is self-administered. DEPENDENT VARIABLES Pain according to the aforementioned scale just after treatment (2 weeks) and at 3 months. Disability according to the aforementioned questionnaire just after the treatment (2 weeks) and at three months. Satisfaction with the treatment right after it (2 weeks) and at three months. A Likert scale of five points ( very satisfied, satisfied, neither satisfied nor unsatisfied, very unsatisfied) will be used. Co-interventions (Systemic and/or topical route drugs, physiotherapy modalities received outside the system, use of orthoses).

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 65 years old * Epicondylosis of three or more months of evolution. * Acceptance of the voluntary participation in the study and signature of the informed consent.

Exclusion criteria

* Generalized musculoskeletal pain. * Rheumatological affections involving of the upper limb. * Cervicobrachialgia. * Previous trauma in upper limb. * Neurological or other pathology that may interfere with the function of the upper limb. * Being out of work or in litigation due to the pathology of the upper limb.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale of painAt two weeksThe Visual Analogue Scale (VAS) quantifies of pain described by the patient with maximum reproducibility among observers. It consists of a 10-centimeter horizontal line, at the ends of which the extreme expressions of a symptom are marked: no pain on the left wiht a score 0, and the highest possible pain on the right wiht a score 10. The patient is asked to mark the point that indicates the intensity in the line and is measured with a millimeter ruler. The intensity is expressed in centimeters or millimeters. A value lower than 4 in the VAS means mild or mild-moderate pain, a value between 4 and 6 implies the presence of moderate-severe pain, and a value greater than 6 implies the presence of very intense pain.
Quick-DashAt two weeksAt least 10 of the 11 questions must be completed to calculate the score Disability / Symptom of Quick DASH. The assigned values for all the complete answers are summed and averaged, giving as a result, a score based on five. This value is then taken to a score based on 100 subtracting 1 and multiplying it by 25. A higher score greater disability.
Satisfaction questionnaireAt two weeksA survey will be carried out to find out what the patient has perceived by asking a question about his satisfaction with the treatment received, choosing one of the following answers: 1. Very satisfied 2. Satisfied 3. Neither satisfied nor unsatisfied 4. Unsatisfied 5. Very unsatisfied

Countries

Spain

Contacts

Primary ContactANTONIO OYA
fisyrec@fisyrec.com+34953266123
Backup ContactJUAN ALFONSO ANDRADE
juanalfonsoandrade@gmail.com34 953 00 80 40

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026